Loomis, Sayles & Company’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-358,393
Closed -$12.2M 1151
2015
Q4
$12.2M Buy
+358,393
New +$12.2M 0.03% 390